Pleomorphic xanthoastrocytoma. Report of four cases.
Four cases of pleomorphic xanthoastrocytoma (PXA), a low-grade leptomeningeal glioma with a reported favorable prognosis affecting young patients, are reported together with a discussion and review of management and prognosis. A literature review has confirmed a favorable prognosis in at least 50% of patients with this disorder. Seventeen of 35 reported patients are still alive and often seizure-free for a mean period of 7.4 years (range 2 to 18 years) after diagnosis. Five patients have died within 2 years and four between 9 and 25 years after diagnosis of PXA. In some cases in which death followed shortly after diagnosis, there may have been histological confusion between PXA and a malignant glioma with heavily lipidized tumor cells. Nonetheless, transformation of PXA into a malignant astrocytoma or glioblastoma with eventual death may occur many years after initial diagnosis. From the currently reported cases it does not appear possible on clinicopathological grounds to predict which patients will have a favorable prognosis. Optimal management of PXA seems to be primary surgical resection with later surgery for residual or recurrent tumor. The role of radiotherapy in the management of PXA is at this time uncertain.
Whittle
I R
IR
Department of Clinical Neurosciences, Western General Hospital, Edinburgh, Scotland.
Gordon
A
A
Misra
B K
BK
Shaw
J F
JF
Steers
A J
AJ
D000293:Adolescent; D000328:Adult; D001254:Astrocytoma / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology / Q000532:radiotherapy / Q000601:surgery; D001932:Brain Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology / Q000532:radiotherapy / Q000601:surgery; D002648:Child; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D011379:Prognosis; D014057:Tomography, X-Ray Computed